Healthcare Realty Trust (HR)

NYSE Real Estate Health Care REITs S&P MidCap 400
$19.20
+0.13 (+0.68%)
Close of Nov 06, 2026 · end-of-day data

HR 8-K filings in 2025

Every material Form 8-K Healthcare Realty Trust filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.

Briefs in 2025815 on record in all
Latest filing in 2025Dec 17, 2025financing
High impact (4-5)5of 8 briefs
TonePositive2Mixed2Neutral4
earnings 3financing 2leadership 2guidance 1
Dec 17, 4:11 PM ET

Healthcare Realty sets up $1 billion at-the-market share sale program

Neutral financing Written later 1.01

Healthcare Realty Trust entered into equity distribution agreements with 16 sales agents for an offering of Class A common stock of up to $1 billion, plus forward sale arrangements with 15 forward purchasers. The company has no obligation to sell any shares and may suspend the program at any time, and it says net proceeds would fund general corporate purposes, including healthcare facility acquisitions and development.

  • Equity Offering Program covers Class A common shares with an aggregate offering price of up to $1,000,000,000
  • Sales agents may receive up to 2.00% of gross proceeds from shares they sell
  • Shares will be issued under a Form S-3ASR registration statement, with a prospectus supplement dated December 17, 2025
Read the filing on SEC.gov ↗
Oct 30, 4:20 PM ET

Healthcare Realty raises 2025 Normalized FFO guidance to $1.59-$1.61 after Q3 results

Positive guidance Written later 2.027.01

Healthcare Realty reported third-quarter 2025 Normalized FFO of $0.41 per share, up from $0.39 a year earlier, and a GAAP net loss of $0.17 per share, narrower than the $0.26 loss in the prior-year quarter. The company raised its 2025 Normalized FFO per share guidance to $1.59-$1.61 and same store cash NOI growth guidance to 4.00%-4.75%, while third-quarter revenue of $297.8 million was below the $315.4 million reported a year earlier.

  • Normalized FFO per share was $0.41 in Q3 2025 versus $0.39 in Q3 2024; NAREIT FFO was $0.34 versus $0.21.
  • GAAP net loss attributable to common stockholders was $57.7 million ($0.17 per share) versus $93.0 million ($0.26 per share) a year earlier.
  • Total revenues were $297.8 million versus $315.4 million in Q3 2024.
  • 2025 guidance: Normalized FFO per share raised to $1.59-$1.61 from $1.57-$1.61; same store cash NOI growth raised to 4.00%-4.75% from 3.25%-4.00%. The board approved a $0.24 per share dividend payable November 21, 2025.
Read the filing on SEC.gov ↗
Jul 31, 4:17 PM ET

Healthcare Realty posts wider Q2 net loss, raises FFO guidance, cuts dividend 23%

Mixed earnings Written later 2.027.01

Healthcare Realty reported a second-quarter GAAP net loss of $0.45 per share, wider than the $0.39 loss a year earlier, while normalized FFO rose to $0.41 per share from $0.38 and the company raised its 2025 normalized FFO guidance by one cent at the midpoint. The board also cut the common dividend 23% to $0.24 per share, which the company said reduces the FAD payout ratio to approximately 80%. New CEO Peter Scott, who joined April 15, is leading a strategic plan and platform restructuring.

  • GAAP net loss attributable to common stockholders was $157.9 million, or $(0.45) per share, versus $143.8 million, or $(0.39) per share, in the second quarter of 2024
  • Normalized FFO was $0.41 per share versus $0.38 a year earlier; 2025 normalized FFO guidance rose to $1.57 to $1.61 from $1.56 to $1.60
  • Quarterly common dividend of $0.24 per share, payable August 28, 2025, to holders of record on August 14, 2025
  • Peter Scott joined as President and CEO on April 15, 2025; the board was reduced from 12 to 7 members
Read the filing on SEC.gov ↗
Jul 31, 4:11 PM ET

Healthcare Realty refinances $1.5 billion revolver and $1.115 billion term loans, extends maturities

Neutral financing Written later 1.012.03

Healthcare Realty Trust and its operating partnership entered a new credit agreement dated July 25, 2025, replacing the existing facility with a $1.5 billion unsecured revolver and five unsecured term loan tranches totaling $1.115 billion. The revolver's maturity was extended from October 31, 2025 to July 25, 2029, which pushes out near-term refinancing needs for shareholders.

  • Revolver maturity extended from October 31, 2025 to July 25, 2029, with two six-month extension options
  • Five term loan tranches totaling $1.115 billion, with maturities ranging from October 31, 2025 to January 20, 2028
  • Current revolver margin is 0.85% per annum over the applicable benchmark, with a range of 0.725% to 1.40% based on credit ratings
  • Wells Fargo Bank, National Association serves as administrative agent
Read the filing on SEC.gov ↗
Jun 23, 6:45 AM ET

Healthcare Realty board shrinks from 12 to 7 members after five directors retire

Neutral leadership Written later 5.027.01

Five Healthcare Realty directors retired from the Board effective June 18, 2025, and the Board immediately reduced its size from 12 to seven members. The company said the change aligns the Board's size with other REIT companies and reflects its governance practices, and the retiring directors reported no disagreement with the company.

  • Retiring directors: Nancy H. Agee, Ajay Gupta, James J. Kilroy, Peter F. Lyle, Sr., and Christann M. Vasquez, effective June 18, 2025
  • Board size reduced from 12 to seven members immediately
  • Remaining directors include independent chairman Thomas Bohjalian, President and CEO Peter Scott, David Henry, Jay Leupp, Constance Moore, Glenn Rufrano and Donald Wood
  • The filing states no executive officer is aware of, and no retiring director has informed the company of, any disagreement with the company
Read the filing on SEC.gov ↗
May 1, 4:17 PM ET

Healthcare Realty posts $44.9 million Q1 net loss, names Peter Scott CEO

Positive earnings Written later 2.027.01

Healthcare Realty reported a first-quarter 2025 net loss attributable to common stockholders of $44.9 million, or $0.13 per diluted share, compared with a $106.8 million loss ($0.31 per share) in the fourth quarter of 2024. The company reaffirmed its 2025 guidance, including normalized FFO of $1.56 to $1.60 per share, and said Peter A. Scott becomes President and CEO on April 15, 2025.

  • Q1 2025 net loss attributable to common stockholders was $44.9 million, or $0.13 per diluted share, versus a $310.8 million loss ($0.82 per share) in Q1 2024
  • Normalized FFO was $0.39 per share in Q1 2025, versus $0.40 in Q4 2024 and $0.39 in Q1 2024
  • Peter A. Scott appointed President and CEO effective April 15, 2025; Connie Moore served as interim CEO from November 2024 until April 14, 2025
  • Quarterly dividend of $0.31 per share payable May 23, 2025, to holders of record on May 12, 2025
Read the filing on SEC.gov ↗
Apr 7, 6:46 AM ET

Healthcare Realty names Peter A. Scott CEO, effective April 15, 2025

Neutral leadership Written later 5.027.01

Healthcare Realty Trust's board appointed Peter A. Scott, formerly chief financial officer of Healthpeak Properties, as president and chief executive officer effective April 15, 2025. Interim CEO Connie Moore is leaving that role but will remain on the board and in a transition role for up to 60 days.

  • Scott's employment agreement sets a base salary of $750,000 and a 2025 annual cash incentive target of 180% of base salary, or $1,350,000.
  • For 2025, Scott's equity awards have a target value of $3,900,000, plus a one-time restricted stock award with a grant date value of $5,750,000 that vests over four years.
  • Scott has served as chief financial officer of Healthpeak Properties since February 2017 and is expected to join the board after the 2025 annual meeting.
  • Moore will receive a monthly salary of $90,000 during a transition role of up to 60 days.
Read the filing on SEC.gov ↗
Feb 19, 6:45 AM ET

Healthcare Realty posts $106.8 million Q4 net loss; names interim CEO Connie Moore

Mixed earnings Written later 2.027.01

Healthcare Realty Trust reported a fourth-quarter 2024 net loss attributable to common stockholders of $106.8 million, or $(0.31) per diluted share, compared with a $40.5 million loss a year earlier, while normalized FFO per share rose to $0.40 from $0.39. The company also named Connie Moore interim President and CEO and guided to a 2025 loss per share of $(0.28) to $(0.20), which matters to shareholders because it signals continued reported losses alongside a leadership transition.

  • Fourth-quarter total revenues were $309.8 million, down from $330.4 million a year earlier.
  • Normalized FFO per share was $0.40 for the quarter, at the high end of prior guidance and up 2.5% year over year.
  • 2025 guidance: earnings per share of $(0.28) to $(0.20) and normalized FFO per share of $1.56 to $1.60.
  • Connie Moore was appointed interim President and CEO, and the board is searching for a permanent CEO; the quarterly dividend is $0.31 per share, payable March 19, 2025.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Healthcare Realty Trust filing is on SEC EDGAR ↗. 8-K briefs of other companies →